EUCRW
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
EUCRW
Delisted
EUCRW was delisted on the 26th of April, 2023.
26 hedge funds and large institutions have $1.09M invested in Eucrates Biomedical Acquisition Corp. Warrant in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
26
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$660K | |
| 2 | +$6K | |
| 3 | +$2K | |
| 4 |
SC
Sculptor Capital
New York
|
+$1K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$378 |
Top Sellers
| 1 | -$6K | |
| 2 | -$5K | |
| 3 | -$4.25K | |
| 4 |
Goldman Sachs
New York
|
-$200 |
| 5 |
BlackRock
New York
|
-$62 |